Valeritas Holdings, Inc. (VLRX)

3.58
NASDAQ
Prev Close 4.14
Day Low/High 2.90 / 4.15
52 Wk Low/High 2.90 / 50.00
Exchange NASDAQ
Shares Outstanding 6.84B
Market Cap 28.33M
Div & Yield N.A. (N.A)

Latest News

Valeritas' V-Go® Wearable Insulin Delivery Device Results In Significant Reductions In A1C, Insulin Requirements And Cost Reductions In Patients With Diabetes

Data presented at the ISPOR 22nd Annual International Meeting, May 20-24, 2017

Valeritas Reports First Quarter 2017 Financial Results

Conference Call and Webcast Today, May 12, at 8:30 a.m. EDT

Valeritas Announces Reverse Stock Split

Valeritas Reports Fourth Quarter And Full Year 2016 Financial Results

Conference Call and Webcast Today, February 21, at 10 a.m. EST

Valeritas Presents Data Showing Greater Reductions In A1c And Insulin Dose With V-Go® Wearable Insulin Delivery Device Compared To Insulin Pen Devices In Patients With Type 2 Diabetes

Data presented at The 10th International Conference on Advanced Technologies & Treatments for Diabetes

Valeritas Promotes Matthew Nguyen To Chief Commercial Officer

Valeritas Promotes Matthew Nguyen To Chief Commercial Officer

Responsible for continued growth of V-Go® Insulin Delivery device for patients with type 2 diabetes